Ronaldo Elkaddoum, John Zakhour, Mary Hajal, Maroun Aoun, Maria Njeim, Mirvat Mahrous, Humaid O Al-Shamsi, Zineb Ben Brahim, Sami A Khatib, Hampig Raphael Kourie
{"title":"通过移动应用程序改进ALK安排的非小细胞肺癌癌症的管理：一项基于物理学的调查。","authors":"Ronaldo Elkaddoum, John Zakhour, Mary Hajal, Maroun Aoun, Maria Njeim, Mirvat Mahrous, Humaid O Al-Shamsi, Zineb Ben Brahim, Sami A Khatib, Hampig Raphael Kourie","doi":"10.2217/pgs-2023-0111","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> ALK rearrangements account for around 5% of non-small-cell lung cancers. <b>Aim:</b> This study surveys physicians on the potential efficacy of a mobile application in improving the management of ALK-rearranged non-small-cell lung cancer, through knowledge, treatment adherence and real-time adverse events reporting. <b>Materials & methods:</b> A total of 118 physicians from 11 countries in the Middle East participated. <b>Results & conclusion:</b> Results indicate 94% support for enhancing team communication via an application, and 93% believe real-time adverse events reporting improves the quality of care. Participants found an ALK-rearrangement patient-physicians forum valuable for communication improvement. Motivations for application use included treatment planning (73%), care enhancement (60%) and contributing to publications (40%).</p>","PeriodicalId":20018,"journal":{"name":"Pharmacogenomics","volume":" ","pages":"725-730"},"PeriodicalIF":1.9000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Improving the management of ALK-rearranged non-small-cell lung cancer through a mobile application: a physicians-based survey.\",\"authors\":\"Ronaldo Elkaddoum, John Zakhour, Mary Hajal, Maroun Aoun, Maria Njeim, Mirvat Mahrous, Humaid O Al-Shamsi, Zineb Ben Brahim, Sami A Khatib, Hampig Raphael Kourie\",\"doi\":\"10.2217/pgs-2023-0111\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> ALK rearrangements account for around 5% of non-small-cell lung cancers. <b>Aim:</b> This study surveys physicians on the potential efficacy of a mobile application in improving the management of ALK-rearranged non-small-cell lung cancer, through knowledge, treatment adherence and real-time adverse events reporting. <b>Materials & methods:</b> A total of 118 physicians from 11 countries in the Middle East participated. <b>Results & conclusion:</b> Results indicate 94% support for enhancing team communication via an application, and 93% believe real-time adverse events reporting improves the quality of care. Participants found an ALK-rearrangement patient-physicians forum valuable for communication improvement. Motivations for application use included treatment planning (73%), care enhancement (60%) and contributing to publications (40%).</p>\",\"PeriodicalId\":20018,\"journal\":{\"name\":\"Pharmacogenomics\",\"volume\":\" \",\"pages\":\"725-730\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2023-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacogenomics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2217/pgs-2023-0111\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/9/14 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2217/pgs-2023-0111","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Improving the management of ALK-rearranged non-small-cell lung cancer through a mobile application: a physicians-based survey.
Background: ALK rearrangements account for around 5% of non-small-cell lung cancers. Aim: This study surveys physicians on the potential efficacy of a mobile application in improving the management of ALK-rearranged non-small-cell lung cancer, through knowledge, treatment adherence and real-time adverse events reporting. Materials & methods: A total of 118 physicians from 11 countries in the Middle East participated. Results & conclusion: Results indicate 94% support for enhancing team communication via an application, and 93% believe real-time adverse events reporting improves the quality of care. Participants found an ALK-rearrangement patient-physicians forum valuable for communication improvement. Motivations for application use included treatment planning (73%), care enhancement (60%) and contributing to publications (40%).
期刊介绍：
Pharmacogenomics (ISSN 1462-2416) is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field.
Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
